Gender differences in the regulation of blood pressure

Hypertension

Volumn 37, Issue 5, 2001, Pages 1199-1208

  Reckelhoff, Jane F ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Hypertension; Nitric oxide; Oxidative stress; Sex characteristics

Indexed keywords

ALDOSTERONE; ANDROGEN; ANGIOTENSIN; ANGIOTENSIN RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ESTROGEN; FLUTAMIDE; GESTAGEN; NITRIC OXIDE; RENIN; TESTOSTERONE; THROMBOXANE B2; VASOCONSTRICTOR AGENT;

AGING; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; DRUG EFFECT; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; KIDNEY DISEASE; MEAN ARTERIAL PRESSURE; MENOPAUSE; NATRIURESIS; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0035714529     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.37.5.1199     Document Type: Review

References (92)

1. 24-h Ambulatory blood pressure in 352 normal Danish subjects, related to age and gender
2. Ambulatory blood pressure monitoring in a nonacademic setting: Effects of age and sex
3. Reference values for ambulatory blood pressure: A meta-analysis
4. Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey, 1988-1991
5. Hypertension in women: What is really known?
6. Sexual dimorphism of blood pressure in spontaneously hypertensive rats: Effects of anti-androgen treatment
7. Gonadectomy-induced reduction in blood pressure in adult spontaneously hypertensive rats
8. Aldosterone, deoxycorticosterone, and prolactin changes during lifespan of chronically and spontaneously hypertensive rats
9. Sexual dimorphism of blood pressure in spontaneously hypertensive rats is androgen dependent
10. Role of vasopressin, the renin-angiotensin system, and sex in Dahl salt-sensitive hypertension
11. Role of gonadal hormones in hypertension in the Dahl salt-sensitive rat
12. Sex difference in the development of deoxycorticosterene-salt hypertension in the rat
13. Sexual dimorphism in renal function and hormonal status of New Zealand genetically hypertensive rats
14. Gender and dietary NaCl in spontaneously hypertensive and Wistar-Kyoto rats
15. Blood pressure in children and adolescents aged 4 to 18: Correlation of blood pressure values with age, sex, body height, body weight, and skinfold thickness
16. Ambulatory blood pressure recordings in children and adolescents
17. Retardation in the development of spontaneous hypertension in SH rats by gonadectomy
18. Effect of castration on the experimental renal hypertension of the rat
19. Sex vulnerability in the subtotal nephrectomy model of glomerulosclerosis in the rat
20. Castration inhibits glomerular hypertrophy and proteinuria in uninephrectomized male rats
21. Gender differences in hypertension in spontaneously hypertensive rats: Role of androgens and androgen receptor
22. Finasteride in the treatment of men with androgenetic alopecia
23. Long-term effects of finasteride on prostate tissue composition
24. Hypertension and virilization caused by a unique dexoxycorticosterone and androgen-secreting adrenal adenoma
25. Coronary heart disease risk factors in women with polycystic ovary syndrome
26. Lipid metabolism in women with polycystic ovary syndrome: Possible implications for an increased risk of coronary heart disease
27. Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats
28. Differences in rat kidney morphology between males, females, and testosterone-treated females
29. Testosterone-induced hypertension in the rat
30. Commentary: Hypertension in women
31. The sexual dimorphism of high blood pressure
32. Blood pressure and menopause transition: The Atherosclerosis Risk in Communities Study (1987-1995)
33. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
34. Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy
35. A randomized trial on effects of hormone therapy on ambulatory blood pressure and lipoprotein levels in women with coronary artery disease
36. Transdennal oestrogen reduces daytime blood pressure in hypertensive women
37. Ambulatory - Not office - Blood pressures decline during hormone replacement therapy in healthy postmenopausal women
38. Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women
39. The effect of hormone replacement therapy on diastolic left ventricular function in hypertensive and normotensive postmenopausal women
40. The HERS trial results: Paradigms lost? Heart and Estrogen/Progestin Replacement Study
41. Induction of calcium dependent NO synthase by sex hormones
42. Increased expression of endothelial constitutive NO gynthase in rat aorta during pregnancy
43. Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with aging
44. Androgen serum levels in women with premature ovarian failure compared to fertile and menopausal controls
45. The endocrine transition around menopause: A five year prospective study with profiles of gonadotropins, estrogens, androgens and SHBG among healthy women
46. Ovarian testosterone secretion during perimenopause
47. Changes in reproductive hormones and sex honnone-binding globulin in a group of postmenopausal women measured over 10 years
48. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: The Rancho Bernardo Study
49. Gender differences in the development of hypertension in SHR: Role of the renin-angiotensin system
50. Role of female sex hormones in the development and reversal of Dahl hypertension
51. Gonadal hormones modulate deoxycorticosterone-salt hypertension in male and female rats
52. Arterial pressure regulation: Overriding dominance of the kidneys in long-term regulation and in hypertension
53. Abnormal pressure-natriuresis: A cause or a consequence of hypertension
54. Remission of hypertension after renal transplantation
55. Control of sodium excretion and arterial pressure by intrarenal mechanisms and the renin-angiotengin system
56. Angiotensin II and Long-term arterial pressure regulation: The overriding dominance of the kidney
57. Localization of androgen receptors in the kidney of male rats
58. Renal transplantation between male and female spontaneously hypertensive rats
59. Role of angiotensin and oxidative stress in essential hypertension
60. Renin relationship to sex, race and age in normotensive population
61. The intravenous furosemide test: A simple way to evaluate renin responsiveness
62. Effects of estrogen replacement therapy on the renin-angiotensin system in post-menopausal women
63. Gender differences in the response of SHR to acute and chronic superoxide dismutase mimetic, TEMPOL
64. Androgen regulation of rat renal angiotensinogen messenger RNA expression
65. Testosterone effect on renin system in rats
66. Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats
67. Intrarenal renin-angiotensin system in renal physiology and pathophysiology
68. A mouse view of hypertension
69. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: Contribution to alterations of vasomotor tone
70. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells
71. The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide
72. Tyrosine modification by reactive nitrogen species: A closer look
73. Peroxynitrite-mediated oxidative protein modifications
74. Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated rat heart
75. Attenuation of vascular relaxation after development of tachyphylaxis to peroxynitrite in vivo
76. Elevation in arterial blood pressure following the development of tachyphylaxis to peroxynitrite
77. 2-isoprostanes in rats
78. The fast and slowly developing pressor effect of angiotensin II
79. Comparison of fast and slow pressor effects of angiotensin II in the rat
80. A series of prostaglandin F2-like compounds are produced in vivo in humans by a noncyclooxygenase, free radical-catalyzed mechanism
81. 2-alpha, in the rat
82. Influence of isoprostanes on vasoconstrictor effects of noradrenaline and angiotensin II
83. Freeradical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells
84. Testosterone increases thromboxane A2 receptors in cultured rat aortic smooth muscle cells
85. The isoprostanes: Unique bioactive products of lipid peroxidation
86. Post-ovariectomy hypertension is linked to upregulation of renal angiotensin II type I (AT1) receptors and increased salt-sensitivity
87. Development of post-ovariectomy hypertension is linked to salt sensitivity
88. Estrogen modulates AT1 receptor gene expression in vitro and in vivo
89. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats
90. Impact of gender on the renal response to angiotensin II
91. Relation between dehydroepiandrosterone sulfate and blood pressure levels in a population-based sample
92. Inhibition of aldosterone production by testosterone in male rats